¾È³çÇϼ¼¿ä ³ª·¡ÀÔ´Ï´Ù.
À̹øÁÖ ¹ßÇ¥³í¹® ¼±Á¤ÇÏ¿© ¾Ë·Áµå¸³´Ï´Ù.
À̹ø¿¡ Á¦°¡ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº 2019³â "Frontiers in immunology"¿¡ °ÔÀçµÈ ³í¹®À¸·Î
º» ¿¬±¸ÆÀÀÌ ±âÁ¸¿¡ ¼±Ç࿬±¸·Î ¹àÇû´ø PRRSV°¨¿°½Ã Áõ°¡ÇÏ´Â IL-1 receptor antagonist(IL-1Ra)ÀÇ immunosuppressive effect¸¦
¼¼Æ÷¼öÁØ¿¡¼ Á» ´õ ÀÚ¼¼ÇÏ°Ô ´Ù·ç°í ÀÖ½À´Ï´Ù.
PRRSV¿¡ °¨¿°µÈ MoDC¿¡¼ ºÐºñµÈ IL-1Ra¿¡ ÀÇÇØ T cellÀÇ differentiation°ú proliferationÀÌ ¾ïÁ¦µÇ´Â Çö»óÀ» IL-10¿¡ ÀÇÇÑ °£Á¢ÀûÀÎ ¿µÇâÀ¸·Î Ç®¾î³»°í ÀÖÀ¸¸ç, MoDC culture systemÀ» ÅëÇØ À̸¦ Áõ¸íÇغ¸ÀÌ°í ÀÖ¾î Á¦ ½ÇÇè¿¡µµ Âü°íÇÒ ¸¸ÇÑ ³»¿ëÀÌ ÀÖÀ» °Í °°¾Æ °øºÎÇغ¸°íÀÚ ¼±Á¤ÇÏ¿´½À´Ï´Ù.
¿½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
³í¹® ¸µÅ©:
https://www.frontiersin.org/articles/10.3389/fimmu.2019.00579/full